Tirzepatide being a dual GLP-one and GIP agonist, it is actually instructed the GIP component of dual agonism could be answerable for the additional gain, specified the potential good thing about GIP receptor agonism on peripheral insulin sensitization. Consequently, tirzepatide was more effective than dulaglutide in decreasing fasting dietary TAG